Page last updated: 2024-10-20

pqq cofactor and Cardiomegaly

pqq cofactor has been researched along with Cardiomegaly in 2 studies

PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research Excerpts

ExcerptRelevanceReference
" However, the therapeutic potential of PQQ for isoproterenol hydrochloride (Iso)‑induced cardiac hypertrophy has not yet been explored, at least to the best of our knowledge."7.96Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway. ( Dai, Z; Jin, Y; Shen, J; Wen, J; Zhao, X; Zhou, Y, 2020)
" However, the therapeutic potential of PQQ for isoproterenol hydrochloride (Iso)‑induced cardiac hypertrophy has not yet been explored, at least to the best of our knowledge."3.96Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway. ( Dai, Z; Jin, Y; Shen, J; Wen, J; Zhao, X; Zhou, Y, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Qu, XF1
Zhai, BZ1
Hu, WL1
Lou, MH1
Chen, YH1
Liu, YF1
Chen, JG1
Mei, S1
You, ZQ1
Liu, Z1
Zhang, LJ1
Zhang, YH1
Wang, Y1
Wen, J1
Shen, J1
Zhou, Y1
Zhao, X1
Dai, Z1
Jin, Y1

Other Studies

2 other studies available for pqq cofactor and Cardiomegaly

ArticleYear
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    European journal of nutrition, 2022, Volume: 61, Issue:4

    Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Glucose

2022
Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway.
    International journal of molecular medicine, 2020, Volume: 45, Issue:3

    Topics: Cardiomegaly; Cell Line; Humans; Isoproterenol; Myocytes, Cardiac; NF-kappa B; PQQ Cofactor; Signal

2020
chemdatabank.com